60 results
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:16pm
in the European Union and has been placed at several hospitals in Europe. FDA 510(k) Clearance in the United States was received in June 2019.
Our
POS AM
VTAK
Catheter Precision Inc.
22 Dec 23
Prospectus update (post-effective amendment)
5:15pm
allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. FDA 510(k) Clearance in the United States
8-K/A
EX-99.3
j03v5kxnoj7xfuj7x1
29 Mar 23
Other Events
4:39pm
PRER14A
ey53n
3 Nov 22
Preliminary revised proxy
9:55pm
PREM14A
n090hpbk
23 Sep 22
Preliminary proxy related to merger
5:28pm
DEFA14A
i1rtord9
9 Sep 22
Additional proxy soliciting materials
8:50pm
8-K
EX-2.1
5sw k2d89im
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
8-K
EX-99.3
b0z35krh gaeu0s1x
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
8-K
EX-99.5
4qg38pq89c qizom9ph7
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
8-K
EX-99.4
27c cyfuuw17j
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
DEFA14A
c3jjo9uml 8myb3mrb6
2 Sep 22
Additional proxy soliciting materials
5:22pm
8-K
EX-10.1
0cx9ctp1zz1htp 9trsf
2 Sep 22
Ra Medical Systems Receives NYSE American Notice
5:21pm